Susquehanna International Group, LLP Cue Biopharma, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$1.24 - $2.18 $53,692 - $94,394
43,300 New
43,300 $53,000
Q4 2023

Feb 14, 2024
BUY
$1.72 - $3.1 $130,548 - $235,290
75,900 New
75,900 $200,000
Q4 2022

Feb 14, 2023
BUY
$2.39 - $3.95 $27,963 - $46,215
11,700 Added 66.1%
29,400 $83,000
Q3 2022

Nov 14, 2022
BUY
$2.23 - $3.37 $1,561 - $2,359
700 Added 4.12%
17,700 $39,000
Q2 2022

Aug 15, 2022
SELL
$2.49 - $5.92 $256,221 - $609,168
-102,900 Reduced 85.82%
17,000 $42,000
Q1 2022

May 16, 2022
BUY
$4.41 - $12.28 $184,779 - $514,532
41,900 Added 53.72%
119,900 $585,000
Q4 2021

Feb 14, 2022
SELL
$10.86 - $17.85 $34,752 - $57,120
-3,200 Reduced 3.94%
78,000 $882,000
Q3 2021

Nov 15, 2021
BUY
$10.06 - $15.3 $480,868 - $731,340
47,800 Added 143.11%
81,200 $1.18 Million
Q2 2021

Aug 11, 2021
BUY
$10.9 - $14.53 $228,900 - $305,130
21,000 Added 169.35%
33,400 $389,000
Q1 2021

May 17, 2021
SELL
$11.2 - $16.09 $47,040 - $67,578
-4,200 Reduced 25.3%
12,400 $151,000
Q3 2020

Nov 16, 2020
SELL
$15.05 - $23.54 $453,005 - $708,554
-30,100 Reduced 64.45%
16,600 $250,000
Q2 2020

Aug 14, 2020
BUY
$12.7 - $30.73 $593,090 - $1.44 Million
46,700 New
46,700 $1.15 Million

Others Institutions Holding CUE

# of Institutions
52
Shares Held
14.1M
Call Options Held
14.4K
Put Options Held
2.6K
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $38.2M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email